NCT03149510

The Effects of Self-monitoring With a Mobile Application in Heart Failure

Completed NA Last updated 2 April 2020

What this trial tests

NA trial testing Mobile Application in Heart Failure in 83 participants. Completed in 30 April 2019.

Timeline

6 March 2017

Primary endpoint
30 April 2019

30 April 2019

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	83
Start date	6 March 2017
Primary completion	30 April 2019
Estimated completion	30 April 2019
Sites	2 locations across United States

Drugs / interventions tested

• Mobile Application

Conditions studied

• Heart Failure — all drugs for Heart Failure →

Sponsor

University of Michigan

Who can join

45 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the United States, about 40 percent of heart failure (HF) patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 70 percent of the costs of HF management. As a result, the management of HF patients is evolving from the traditional model of face-to-face follow-up visits toward a proactive real-time technological model of assisting patients with monitoring and self-management while in the community. The investigators plan to test the impact of a mobile application on clinical outcomes in HF.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. mHealth education interventions in heart failure.
   Allida S, Du H, Xu X, Prichard R, et al · · 2020 · cited 47× · PMID 32613635 · DOI 10.1002/14651858.cd011845.pub2
2. The Effects of the ManageHF4Life Mobile App on Patients With Chronic Heart Failure: Randomized Controlled Trial.
   Dorsch MP, Farris KB, Rowell BE, Hummel SL, et al · · 2021 · cited 39× · PMID 34878990 · DOI 10.2196/26185